GlassScriptPhysician profile
Michael N Funk
NPI 1891956975
$15,519.31
in general payments reported to CMS, 2019-2025
54 companies · $1,904 in 2025
The $1,904 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,866 · 2020: $1,660 · 2021: $2,466 · 2022: $2,641 · 2023: $2,025 · 2024: $1,957 · 2025: $1,904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,886.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,859.17 | 2019-2025 | Jot Dx, Freestyle Libre 2, Navitor |
| Medtronic, INC. | $1,573.63 | 2021-2025 | Cobalt Dr Mri Surescan, Percepta Quad Crt-P Mri Surescan, Linq II |
| Novo Nordisk INC | $1,383.31 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,273.48 | 2019-2025 | Jardiance |
| Amgen INC. | $1,024.45 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $991.26 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $650.31 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $627.26 | 2019-2025 | Farxiga |
| Boston Scientific Corporation | $583.57 | 2021-2025 | Watchman Flx, General - Therapies, Bodyguardian |
| Pfizer INC. | $441.49 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $398.72 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $308.35 | 2019-2023 | |
| Philips North America LLC | $296.60 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Lilly USA, LLC | $275.73 | 2020-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $207.08 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $191.70 | 2022-2025 | |
| Amarin Pharma, INC. | $176.73 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $175.97 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $164.70 | 2020-2023 | Contrave, Onzetra Xsail, Nexlizet |
| Impulse Dynamics (USA) INC. | $150.38 | 2022-2023 | Optimizer |
| Edwards Lifesciences Corporation | $119.71 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.16 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $102.98 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $101.95 | 2024-2025 | Voquezna |
| Kiniksa Pharmaceuticals, LTD. | $94.91 | 2021-2023 | Arcalyst |
| Cvrx, INC. | $91.83 | 2023-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $83.40 | 2024 | Arcalyst |
| Biotronik INC. | $80.34 | 2021-2023 | Biomonitor |
| Corcept Therapeutics | $76.16 | 2025 | Korlym |
| Azurity Pharmaceuticals, INC. | $70.48 | 2023-2024 | Horizant, Horizant |
| Kestra Medical Technology Services, INC. | $69.22 | 2025 | Assure Wcd |
| Saluda Medical Americas, INC. | $63.21 | 2025 | Evoke |
| Abbvie INC. | $62.75 | 2023 | |
| Baxter Healthcare | $61.55 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Medicomp INC | $57.81 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $54.95 | 2019 | |
| Exact Sciences Corporation | $51.83 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $45.22 | 2021-2025 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $43.74 | 2020-2022 | |
| Vivus LLC | $35.25 | 2021-2024 | Pancreaze |
| Esperion Therapeutics, INC. | $32.99 | 2022-2024 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $26.46 | 2024 | Rexulti |
| Actelion Pharmaceuticals US, INC. | $24.53 | 2022 | |
| Agepha Pharma Fz LLC | $22.94 | 2024 | Lodoco |
| Amneal Pharmaceuticals LLC | $22.62 | 2025 | Unithroid |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.05 | 2020 | |
| Merz North America, INC. | $19.67 | 2021 | |
| Medtronic Vascular, INC. | $18.73 | 2020 | |
| Astellas Pharma US INC | $18.38 | 2023 | Veozah |
| Vifor Pharma, INC. | $17.57 | 2019 | |
| Gilead Sciences, INC. | $15.74 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.96 | 2025 | Caplyta |
| Evoke Pharma, INC. | $14.27 | 2023 | Gimoti |
| Madrigal Pharmaceuticals | $14.06 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Funk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.